Ventfort
Khavinson natural peptide complex derived from blood vessel tissue — the Cytomax counterpart to synthetic Vesugen. Used for vascular health, atherosclerosis prevention, and endothelial function.
🔬 Mechanism of Action
Ventfort is a Khavinson Cytomax derived from blood vessel tissue — the natural extract counterpart to synthetic Vesugen (KED). It contains multiple vascular endothelial and smooth muscle peptides for comprehensive vascular support.
Ventfort modulates: (1) endothelial nitric oxide synthase (eNOS) for vasodilation and anti-thrombotic function, (2) elastin and collagen type IV expression for vessel wall elasticity, (3) vascular smooth muscle cell phenotype — promoting the contractile (healthy) phenotype over the synthetic (pro-atherogenic) phenotype, and (4) endothelial progenitor cell mobilization for vascular repair.
In Khavinson cardiovascular protocols, Ventfort is used for peripheral vascular disease, age-related arterial stiffness, post-revascularization support, and cardiovascular risk reduction.
Source: PMID: 15677927
📜Background & History
Ventfort is the vascular Cytomax extract — natural counterpart to synthetic Vesugen.
🎯 Research Use Cases
- ✓Vascular health
- ✓Endothelial function
- ✓Atherosclerosis prevention
💉 Dosing Protocol
| Typical Dose | 1-2 capsules/day |
| Frequency | 1-2× daily for 10-30 day cycles |
| Half-Life | ~30 minutes (estimated) |
⚠️Safety & Considerations
Standard oral Cytomax capsule protocol. Well tolerated.
⚡Interactions & Contraindications
Standard Cytomax capsule protocol.
🔗Synergies & Common Stacks
Ventfort (Cytomax) + Vesugen (synthetic) = comprehensive vascular bioregulator support.